The compliance
advantage in cannabis.
Medicexum is the regulatory and commercial partner for suppliers, importers and clinics building inside the UK's most scrutinised emerging market.
Which licences does your operation actually need?
Four questions. An indicative regulatory stack in under a minute.
Founder, Medicexum
Twenty five years of pharmaceutical quality, applied to cannabis.
Wilson's career was built in pharmaceutical quality and validation, across GSK, Sanofi, AstraZeneca, Fujifilm Diosynth and Novartis, including commissioning, qualification and remediation programmes run to MHRA and FDA expectations. That is where the standard comes from.
He went on to lead quality and operations for a team of more than two hundred, and held a Global Head of Quality role inside a FTSE 100 business. Medicexum applies that standard to a market where most operators are still learning it as they go.
- Responsible Person (GDP), Cogent Skills gold standard
- Associate, Chartered Quality Institute
- IATCA certified Lead Auditor
- BSc (Hons) Biotechnology
- GSK
- SANOFI
- ASTRAZENECA
- FUJIFILM DIOSYNTH
- NOVARTIS
- IMPERIAL BRANDS
We don't just advise on compliance systems. We build them.
Four production compliance tools, built in house. Two are free to use.
We don't just quote the science.
We index it.
A live library of peer reviewed cannabis research, regulatory bulletins and ongoing trials, graded, tagged and updated weekly. Built for clinicians, importers and policy teams who need evidence at hand.
- Grade A134
- Grade B165
- Grade C130
- Grade D71
Latest thinking
Compliance is no longer a cost centre. It is the moat. The operators who treat MHRA, GDP and EU GMP as a strategic asset will define the UK market for the next decade.